In the same year, Vujic et al. successfully used metformin to inhibit cell proliferation and induce apoptosis in NRAS mutant NB cell lines (SK-N-AS and CHP-212), in which NRAS signaling is constitutively active through the PI3K/AKT/mTOR pathway [32]. This evidence concerns the gene NRAS and neuroblastoma.